MarketResearchNest.com adds “Global Robotic General Surgery Market 2017-2021” new reports to its research database. The report spread across 85 pages with tables and figures in it.
The analysts forecast the global robotic general surgery market to grow at a CAGR of 10.53% during the period 2017-2021.
Robotic surgery or robot-assisted surgery is a minimally invasive surgery that integrates advanced computer technology, which provides 10x magnified, high-definition, and 3D-image of the body’s intricate anatomy. Robotic surgery systems are used in a wide range of surgical procedures including general surgery, colorectal, cardiac, head and neck, gynecologic, thoracic, and urologic surgical procedures. Some of the general surgery procedures where robotic surgical systems are used are bariatric surgery (gastric bypass and sleeve gastrectomy), Heller myotomy, stomach cancer surgery, hernia repair, cholecystectomy, Nissen fundoplication, and pancreatectomy. Robotic surgery offers several advantages such as a 3D view of the operating field, low risk of infection, reduced blood loss and transfusions, fast recovery time, early discharge from hospital, minimal scarring, less post-operative pain and trauma to the body, and more precision in surgery due to the elimination of surgeon’s tremor.
Get more details about report at https://www.marketresearchnest.com/global-robotic-general-surgery-market-2017-2021.html .
Technavio recognizes the following companies as the key players in the global robotic general surgery market: Accuray, Intuitive Surgical, Medrobotics Corporation, and TransEnterix Surgical
Other Prominent Vendors in the market are: meerecompany, Titan Medical, Verb Surgical, and Virtual Incision Corporation.
Commenting on the report, an analyst team said: “The latest trend gaining momentum in the market is Technological advances. Many new vendors are increasingly focusing on developing technologically advanced robotic surgical systems. For instance, in May 2017 and October 2016, Medrobotics Corporation received the regulatory clearance to market its Flex Robotic System for colorectal procedures in the US and Europe, respectively. The Flex Robotic System is the first minimally invasive robotic surgical system in the world with a steerable and shapeable robotic scope. It is also the first robotic surgical system in the world to offer Scarfree surgical access to hard-to-reach anatomy in colorectal and otolaryngology surgical procedures that might otherwise be inaccessible with straight surgical tools.”
Request a Sample Report Copy at https://www.marketresearchnest.com/requestsample.php?reportid=285079 .
According to the report, one of the major drivers for this market is Increasing number of general surgery procedures. There is a high incidence of gastrointestinal diseases and conditions such as pancreatic cancer, obesity, hernia, cholelithiasis, and cholecystitis. In 2012, there were approximately 47,400 new diagnosed cases of pancreatic cancer per billion population in the world. According to the Centers for Disease Control and Prevention (CDC), as of 2014, more than one-third of the US adults were obese. Obese patients are more likely to undergo bariatric surgeries such as gastric bypass and sleeve gastrectomy. More than six million laparoscopic procedures are being performed across the US and CE Mark countries every year.
Further, the report states that one of the major factors hindering the growth of this market is High cost of robotic general surgery devices. The high cost of robotic general surgery devices is significantly affecting their adoption. For instance, CyberKnife, offered by Accuray, costs approximately $4 million-$5 million. The da Vinci Surgical System, offered by Intuitive Surgical, costs approximately $0.5 million-$2.5 million depending upon the configuration, model, and geography. According to an article published in the Obstetrics and Gynecology International, to amortize the initial capital of robotic surgical systems, the robotic surgery system should be used to perform more than 300 surgical procedures per year for seven years, which is equivalent to an amount of over 1,100 dollars per patient.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Order a Purchase Report Copy at https://www.marketresearchnest.com/purchase.php?reportid=285079 .
MarketResearchNest.com is the most comprehensive collection of market research products and services on the Web. We offer reports from almost all top publishers and update our collection on daily basis to provide you with instant online access to the world’s most complete and recent database of expert insights on global industries, organizations, products, and trends.
Mr. Jeet Jain
+1-240-284-8070 / +44-20-3290-4151